MOLEAC PTE LTD
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
NeuroAiD has shown favourable outcome in patients suffering from spinal cord injuries 2022-06-06 18:07
NeuroAiD(TM)II holds promise as a safe add-on therapy to standard Alzheimer Disease symptomatic treatments and may have a disease modifying effect by delaying disease progression 2022-01-13 12:32
Moleac Announces US FDA Approval of IND Application for Phase 1 Study of MLC1501 Programme in Post-Traumatic Brain Injury Recovery 2021-05-31 18:33
Moleac Pte Ltd wins SBR National Business Award for Pharmaceuticals 2021-05-06 18:12
Moleac Announces US FDA Approval of IND Application for Phase 1 Study of MLC1501 Programme in Post-Traumatic Brain Injury Recovery 2021-04-14 19:15
NeuroAiD combined with rehabilitation has shown additive and sustained benefits on post-stroke recovery over 2 years after an initial 3-month treatment following stroke onset 2018-09-28 21:00
Moleac Announces US FDA Approval of IND Application for Phase 1 Study of MLC1501 Programme in Post-Stroke Recovery 2018-03-05 22:00
Moleac's Flagship Product NeuroAiD Named Asia Pacific Neurological Disorders New Product Innovation of the Year At the Frost & Sullivan Best Practices Awards 2016-10-14 00:01
NeuroAiD(TM) has shown persistent long-term benefits after an initial 3-month treatment following stroke onset 2015-06-10 18:00
NeuroAiD, a Stroke Treatment Based on Traditional Medicine Increases Chances of Recovery 2013-07-03 14:00
NeuroAiD, a Stroke Treatment Based on Traditional Chinese Medicine Increases Chances of Recovery 2013-06-22 01:26
NeuroAiD, a Stroke Treatment Based on Traditional Chinese Medicine Increases Chances of Recovery 2013-06-21 18:39
1